The counterfeit clampdown

pharmafile | June 27, 2008 | Feature | Manufacturing and Production |  Europe, counterfeits, parallel trade 

Related Content

EC approves combination treatment for kidney cancer

The European Commission (EC) has approved Ipsen’s Cabometyx in combination with Opdivo as a first-line …

spravato

Janssen’s esketamine nasal spray gets Europe approval for new indication

The European Commission (EC) has authorised the expanded use of Janssen’s Spravato (esketamine nasal spray), co-administered …

xellia

Xellia Pharmaceuticals becomes member of Medicines for Europe

Xellia Pharmaceuticals, a manufacturer of specialty anti-infective treatments, has become a member of Medicines for …

The Gateway to Local Adoption Series

Latest content